Palisade Bio (7NS0) Ownership - Who Owns Palisade Bio?
Palisade Bio (7NS0) Ownership Overview
- 4.65% Insiders
- 7.59% Mutual Funds
- 0.31% Other Institutional Investors
- 9.39% ETFs
- 78.05% Public Companies and Individual Investors
The ownership structure of Palisade Bio (DE:7NS0) stock is a mix of institutional, retail, and individual investors. Approximately 17.30% of the company’s stock is owned by Institutional Investors, 4.65% is owned by Insiders, and 78.05% is owned by Public Companies and Individual Investors.
The ownership structure of Palisade Bio (DE:7NS0) stock is a mix of institutional, retail, and individual investors. Approximately 17.30% of the company’s stock is owned by Institutional Investors, 4.65% is owned by Insiders, and 78.05% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jul 09, 2026 | Robert Baltera | $88,350 | |
| Jul 07, 2026 | Robert Baltera | $101,900 | |
| Jul 05, 2026 | Robert Baltera | $59,400 | |
| Jan 20, 2026 | Donald Allen Williams | $8,350 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Platinum Investment Management | €1,560,604 | |
| Dec 31, 2025 | Ra Capital Management | €16,741,672 | |
| Dec 31, 2025 | Perceptive Advisors Llc | €28,317,500 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 10,436,760 | Institution | 5.99% | 58,351,925 |
| Vanguard | 8,729,533 | Institution | 5.01% | 48,806,819 |
| Joseph Edelman | 8,425,065 | Institution | 4.83% | 47,104,538 |
| Peter Kolchinsky | 7,124,116 | Institution | 4.09% | 39,830,933 |
| Ishares | 6,242,327 | Institution | 3.58% | 34,900,850 |
| Federated Hermes Equity Funds | 3,136,607 | Institution | 1.80% | 17,536,770 |
| Franklin Strategic Series | 2,119,910 | Institution | 1.22% | 11,852,417 |
| John David Finley | 2,033,141 | Insider | 1.17% | 11,367,291 |
| Fidelity Salem Street Trust | 1,804,815 | Institution | 1.04% | 10,090,721 |
| Marcia Venegas | 1,730,866 | Institution | 0.99% | 9,677,272 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Federated Hermes Equity Funds | 3,136,607 | Institution | 1.80% | 17,536,770 |
| Franklin Strategic Series | 2,119,910 | Institution | 1.22% | 11,852,417 |
| Fidelity Salem Street Trust | 1,804,815 | Institution | 1.04% | 10,090,721 |
| Vanguard Index Funds | 1,722,817 | Institution | 0.99% | 9,632,270 |
| Fidelity Concord Street Trust | 1,333,877 | Institution | 0.77% | 7,457,706 |
| Vanguard Scottsdale Funds | 997,096 | Institution | 0.57% | 5,574,764 |
| Tiaa-cref Funds | 969,457 | Institution | 0.56% | 5,420,234 |
| Schwab Capital Trust | 434,983 | Institution | 0.25% | 2,431,990 |
| Sei Institutional Investments Trust | 412,900 | Institution | 0.24% | 2,308,524 |
| Goldman Sachs Trust | 101,600 | Institution | 0.06% | 568,046 |
FAQ
Who Owns Palisade Bio (DE:7NS0)?
According to the latest TipRanks data, approximately 17.30% of the company's stock is held by institutional investors, 4.65% is held by insiders, and 78.05% is held by public companies and individual investors.
What percentage of Palisade Bio (DE:7NS0) stock is held by institutional investors?
According to the latest TipRanks data, approximately 17.30% of Palisade Bio (DE:7NS0) stock is held by institutional investors: 7.59% by mutual funds, 9.39% by ETFs and 0.31% by other institutional investors.
What percentage of Palisade Bio (DE:7NS0) stock is held by retail investors?
According to the latest TipRanks data, approximately 78.05% of Palisade Bio (DE:7NS0) stock is held by public companies and individual investors.
Who owns the most shares of Palisade Bio (DE:7NS0)?
BlackRock, Inc. owns the most shares of Palisade Bio (DE:7NS0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
